Selective serotonin reuptake inhibitors. Unsuccessful treatment may be related to non-response or non-compliance.
作者信息
Henry J A, Hale A S
出版信息
BMJ. 1994 Oct 22;309(6961):1083; author reply 1085.
Abstract
摘要
相似文献
1
Selective serotonin reuptake inhibitors. Unsuccessful treatment may be related to non-response or non-compliance.选择性5-羟色胺再摄取抑制剂。治疗失败可能与无反应或不依从有关。
BMJ. 1994 Oct 22;309(6961):1083; author reply 1085.
2
Selective serotonin reuptake inhibitors. Calculation of costs is incorrect.选择性5-羟色胺再摄取抑制剂。成本计算有误。
BMJ. 1994 Oct 22;309(6961):1082-3; author reply 1085.
3
Selective serotonin reuptake inhibitors. Hidden costs ignored.选择性5-羟色胺再摄取抑制剂。被忽视的潜在成本。
BMJ. 1994 Oct 22;309(6961):1083; author reply 1085.
4
Selective serotonin reuptake inhibitors. Total profile of drug should be considered.选择性5-羟色胺再摄取抑制剂。应考虑药物的整体情况。
BMJ. 1994 Oct 22;309(6961):1083; author reply 1085.
5
Selective serotonin reuptake inhibitors. Methodology is inadequately described.选择性5-羟色胺再摄取抑制剂。方法描述不充分。
BMJ. 1994 Oct 22;309(6961):1084-5.
6
Selective serotonin reuptake inhibitors. Conflicting reports confuse prescribers.选择性5-羟色胺再摄取抑制剂。相互矛盾的报告让开处方的医生感到困惑。
BMJ. 1994 Oct 22;309(6961):1084; author reply 1085.
7
Selective serotonin reuptake inhibitors. Authors' assumptions are misleading.选择性5-羟色胺再摄取抑制剂。作者的假设具有误导性。
BMJ. 1994 Oct 22;309(6961):1084; author reply 1085.
8
Selective serotonin reuptake inhibitors. Commercial interests should not influence prescribing.选择性5-羟色胺再摄取抑制剂。商业利益不应影响处方开具。
BMJ. 1994 Oct 22;309(6961):1083-4; author reply 1085.
9
Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Selective serotonin reuptake inhibitors for major depression.
Int J Technol Assess Health Care. 1998 Spring;14(2):394-6. doi: 10.1017/s0266462300012356.
10
Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxiety.文拉法辛和选择性5-羟色胺再摄取抑制剂治疗抑郁和焦虑的费用
Manag Care Interface. 2002 Jun;15(6):24-30.
引用本文的文献
1
Selective serotonin reuptake inhibitors. Assessment for formulary inclusion.
Pharmacoeconomics. 1996 May;9(5):430-42. doi: 10.2165/00019053-199609050-00006.
本文引用的文献
1
Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression.全剂量与半剂量药物疗法在复发性抑郁症维持治疗中的比较
J Affect Disord. 1993 Mar;27(3):139-45. doi: 10.1016/0165-0327(93)90001-z.
2
Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.选择性5-羟色胺再摄取抑制剂：停药率的荟萃分析
Int Clin Psychopharmacol. 1994 Spring;9(1):47-53. doi: 10.1097/00004850-199400910-00008.
3
Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide.将选择性5-羟色胺再摄取抑制剂作为预防自杀的策略。
BMJ. 1994 Jul 23;309(6949):249-53. doi: 10.1136/bmj.309.6949.249.
4
Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.氟西汀与自杀：抑郁症治疗对照试验的荟萃分析
BMJ. 1991 Sep 21;303(6804):685-92. doi: 10.1136/bmj.303.6804.685.
Zotero 插件